Newtrend Group: Dr. Li Ling Steps Down, Cornell-Trained Scientist Dr. Zhang Xi Joins as Independent Director

Bulletin Express05-14

Newtrend Group Holding Co., Ltd. (Newtrend Group) announced a board reshuffle effective 14 May 2026.

Dr. Li Ling resigned as Independent Non-Executive Director (INED) and as a member of both the Audit Committee and the Nomination Committee to focus on other business commitments. The company confirmed that Dr. Li had no disagreements with the board and no matters requiring shareholder attention.

To fill the vacancy, the board appointed Dr. Zhang Xi, aged 37, as an INED. Dr. Zhang, who holds a Ph.D. in Food Science from Cornell University, is currently Deputy General Manager of GENEDART Biotechnology Co., Ltd. Her background spans product R&D, technology transfer, and regulatory affairs in human and animal nutrition. Previous roles include R&D Director at Shenzhen Kexing Tianhe Biotechnology and Medical Director at Kexing Biopharm. Dr. Zhang will receive annual director’s emoluments and allowances of RMB 0.06 million and will serve until the forthcoming AGM, where she will be eligible for re-election.

Committee composition after the changes: • Audit Committee: Dr. Song Jingjin (Chair), Mr. Lo Kwing Yu, Dr. Zhang Xi • Nomination Committee: Mr. Wang Xiaoqiang (Chair), Dr. Song Jingjin, Dr. Zhang Xi

The board expressed gratitude to Dr. Li for her service and welcomed Dr. Zhang’s appointment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1140411217?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140411217","market":"hk","top_or_hot":-1,"title":"Newtrend Group: Dr. Li Ling Steps Down, Cornell-Trained Scientist Dr. Zhang Xi Joins as Independent Director","media":"Bulletin Express","content":"<p>Newtrend Group Holding Co., Ltd. (Newtrend Group) announced a board reshuffle effective 14 May 2026.</p>\n<p>Dr. Li Ling resigned as Independent Non-Executive Director (INED) and as a member of both the Audit Committee and the Nomination Committee to focus on other business commitments. The company confirmed that Dr. Li had no disagreements with the board and no matters requiring shareholder attention.</p>\n<p>To fill the vacancy, the board appointed Dr. Zhang Xi, aged 37, as an INED. Dr. Zhang, who holds a Ph.D. in Food Science from Cornell University, is currently Deputy General Manager of GENEDART Biotechnology Co., Ltd. Her background spans product R&D, technology transfer, and regulatory affairs in human and animal nutrition. Previous roles include R&D Director at Shenzhen Kexing Tianhe Biotechnology and Medical Director at Kexing Biopharm. Dr. Zhang will receive annual director’s emoluments and allowances of RMB 0.06 million and will serve until the forthcoming AGM, where she will be eligible for re-election.</p>\n<p>Committee composition after the changes:\n• Audit Committee: Dr. Song Jingjin (Chair), Mr. Lo Kwing Yu, Dr. Zhang Xi  \n• Nomination Committee: Mr. Wang Xiaoqiang (Chair), Dr. Song Jingjin, Dr. Zhang Xi</p>\n<p>The board expressed gratitude to Dr. Li for her service and welcomed Dr. Zhang’s appointment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Newtrend Group: Dr. Li Ling Steps Down, Cornell-Trained Scientist Dr. Zhang Xi Joins as Independent Director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNewtrend Group: Dr. Li Ling Steps Down, Cornell-Trained Scientist Dr. Zhang Xi Joins as Independent Director\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-14 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Newtrend Group Holding Co., Ltd. (Newtrend Group) announced a board reshuffle effective 14 May 2026.</p>\n<p>Dr. Li Ling resigned as Independent Non-Executive Director (INED) and as a member of both the Audit Committee and the Nomination Committee to focus on other business commitments. The company confirmed that Dr. Li had no disagreements with the board and no matters requiring shareholder attention.</p>\n<p>To fill the vacancy, the board appointed Dr. Zhang Xi, aged 37, as an INED. Dr. Zhang, who holds a Ph.D. in Food Science from Cornell University, is currently Deputy General Manager of GENEDART Biotechnology Co., Ltd. Her background spans product R&D, technology transfer, and regulatory affairs in human and animal nutrition. Previous roles include R&D Director at Shenzhen Kexing Tianhe Biotechnology and Medical Director at Kexing Biopharm. Dr. Zhang will receive annual director’s emoluments and allowances of RMB 0.06 million and will serve until the forthcoming AGM, where she will be eligible for re-election.</p>\n<p>Committee composition after the changes:\n• Audit Committee: Dr. Song Jingjin (Chair), Mr. Lo Kwing Yu, Dr. Zhang Xi  \n• Nomination Committee: Mr. Wang Xiaoqiang (Chair), Dr. Song Jingjin, Dr. Zhang Xi</p>\n<p>The board expressed gratitude to Dr. Li for her service and welcomed Dr. Zhang’s appointment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02573","symbol_name":"新琪安","start_time":0,"source_url":"","article_id":"1140411217","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140411217","pubTimestamp":1778769780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Newtrend Group Holding Co., Ltd. (Newtrend Group) announced a board reshuffle effective 14 May 2026. Dr. Li Ling resigned as Independent Non-Executive Director (INED) and as a member of both the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02573":"新琪安"},"translate_title":"新趋势集团：李玲博士卸任康乃尔培养的科学家张*博士加入独立董事","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02573":1},"content_text":"Newtrend Group Holding Co., Ltd. (Newtrend Group) announced a board reshuffle effective 14 May 2026.\nDr. Li Ling resigned as Independent Non-Executive Director (INED) and as a member of both the Audit Committee and the Nomination Committee to focus on other business commitments. The company confirmed that Dr. Li had no disagreements with the board and no matters requiring shareholder attention.\nTo fill the vacancy, the board appointed Dr. Zhang Xi, aged 37, as an INED. Dr. Zhang, who holds a Ph.D. in Food Science from Cornell University, is currently Deputy General Manager of GENEDART Biotechnology Co., Ltd. Her background spans product R&D, technology transfer, and regulatory affairs in human and animal nutrition. Previous roles include R&D Director at Shenzhen Kexing Tianhe Biotechnology and Medical Director at Kexing Biopharm. Dr. Zhang will receive annual director’s emoluments and allowances of RMB 0.06 million and will serve until the forthcoming AGM, where she will be eligible for re-election.\nCommittee composition after the changes:\n• Audit Committee: Dr. Song Jingjin (Chair), Mr. Lo Kwing Yu, Dr. Zhang Xi  \n• Nomination Committee: Mr. Wang Xiaoqiang (Chair), Dr. Song Jingjin, Dr. Zhang Xi\nThe board expressed gratitude to Dr. Li for her service and welcomed Dr. Zhang’s appointment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1140411217","isCrawlerRequest":true}